Schizophrenia- A Story Meant to be Painted

 

This is a story about my Schizophrenia meant to be painted. The years after college   my father passed away on Jan. 2, 2007, due to natural causes and then my sister died the very next day in a car accident on her way to the funeral. I cannot express the pain and anguish that came over me.I suppose all people who are affected by mental illness have that moment when “it” happens—the moment when their condition makes itself known. My moment happened when I was an undergraduate in college. It was in the form of voices, hallucinations and paranoid thoughts that one of my professors was trying to kill me.

Continue Reading →

Sydni’s Mental Health Journey

One weekend in June of 2017, our lives, the lives of our family, and most importantly, the life of our daughter Sydni, changed forever.

by Traci Quinn

We are shocked and heartbroken that our perfect daughter Sydni will have to battle this Mental Illness for the rest of her life.  Our families’ journey since then has been difficult, with the past six months being the worst. Sydni’s been hospitalized four times since her diagnosis. One of the things that can help our daughter in her recovery is her own “space”.

She was diagnosed with Bipolar/Schizoaffective Disorder at seventeen.  A brain disease that causes depression, mood swings, hearing voices, erratic behaviors and self harm/suicidal ideations.

 

Continue Reading →

Medication Helps Some With Mild Depression

Medication Helps Some With Mild Depression

  People with mild depression may benefit from antidepressants, suggests a new meta-analysis.

Some earlier reports had suggested that antidepressants generally only improve mood in people with severe depression. But that might be because those studies weren’t precise enough to pick up on smaller changes in symptoms that can still make a difference for people with milder forms of the disease, researchers on the new study said. Continue Reading →

FDA Approves Tapentadol for Chronic Pain


FDA Approves Tapentadol for Chronic Pain

 
 The US Food and Drug Administration (FDA) has approved tapentadol extended release (Nucynta, Janssen Pharmaceuticals) for moderate to severe chronic pain.

The drug, already approved for acute pain, has now been given the okay for long-term use, the company announced today. In Europe, tapentadol is marketed as Palexia.

Continue Reading →